Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Preparation of chitosan-containing nanofibres by electrospinning of chitosan/poly(ethylene oxide) blend solutions

Preparation of chitosan-containing nanofibres by electrospinning of chitosan/poly(ethylene oxide)... AbstractThe first successful preparation of chitosan-containing nanofibres was achieved by electrospinning of chitosan/poly(ethylene oxide) (PEO) blend aqueous solutions. The diameters of the nanofibres were in the range 40 - 290 nm and decreased with increasing chitosan content and decreasing total concentration. An increase of the applied field strength leads to an increase of the diameter of the nanofibres and to a broadening of the size distribution. The possibility to prepare nanofibres containing a model drug - potassium 5-nitro-8-quinolinolate (K5N8Q), a broad-spectrum antimicrobial and antimycotic agent - was shown. The incorporation of K5N8Q in the nanofibres resulted in a decrease of the nanofibre diameters and the appearance of bead-shaped defects. Non-woven mats from the drugloaded nanofibres with composition chitosan : PEO = 1:1 (w/w) and 1% K5N8Q showed antibacterial and antimycotic activity against E. coli, S. aureus and C.albicans. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png e-Polymers de Gruyter

Preparation of chitosan-containing nanofibres by electrospinning of chitosan/poly(ethylene oxide) blend solutions

Loading next page...
 
/lp/de-gruyter/preparation-of-chitosan-containing-nanofibres-by-electrospinning-of-QJaYvmDpMl
Publisher
de Gruyter
Copyright
© 2013 by Walter de Gruyter GmbH & Co.
ISSN
2197-4586
eISSN
1618-7229
DOI
10.1515/epoly.2004.4.1.624
Publisher site
See Article on Publisher Site

Abstract

AbstractThe first successful preparation of chitosan-containing nanofibres was achieved by electrospinning of chitosan/poly(ethylene oxide) (PEO) blend aqueous solutions. The diameters of the nanofibres were in the range 40 - 290 nm and decreased with increasing chitosan content and decreasing total concentration. An increase of the applied field strength leads to an increase of the diameter of the nanofibres and to a broadening of the size distribution. The possibility to prepare nanofibres containing a model drug - potassium 5-nitro-8-quinolinolate (K5N8Q), a broad-spectrum antimicrobial and antimycotic agent - was shown. The incorporation of K5N8Q in the nanofibres resulted in a decrease of the nanofibre diameters and the appearance of bead-shaped defects. Non-woven mats from the drugloaded nanofibres with composition chitosan : PEO = 1:1 (w/w) and 1% K5N8Q showed antibacterial and antimycotic activity against E. coli, S. aureus and C.albicans.

Journal

e-Polymersde Gruyter

Published: Dec 1, 2004

There are no references for this article.